Products for Research Use Only
RegisterLogin

SYHA1813

CAT: 0804-HY-161025-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-161025-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
SYHA1813 is a dual inhibitor of CSF1R and VEGFR. SYHA1813 has potent antitumor activity against GBM[1].
CAS Number
1807466-30-3
UNSPSC
12352005
Target
C-Fms; VEGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/syha1813.html
Purity
99.46
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
NC1=NNC2=C1C(C3=CC=C4C(C=CC=C4C(NC5=CC=C(F)C(C)=C5)=O)=C3)=CC=C2
Molecular Formula
C25H19FN4O
Molecular Weight
410.44
References & Citations
[1]Yingqiang Liu, et al. Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood-brain barrier and exhibits potent activity against glioblastoma. Acta Pharm Sin B. 2023, 13,12.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
Phase 2

Related Products

CatalogName
HY-149451SYHA1815

Alternative Products

CatalogName
BA8863-1SYHA1813

Popular Products